Associate Director Scientific Writing

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

Translational Development (TD) is part of the Global Research and Early Development organization in BMS and leads mid- to late-stage clinical, pharmacological, and translational research and development activities for the BMS pipeline. The Translational Development team supports the late-stage portfolio for regulatory, development and life cycle management. Translational Development at BMS has a long-standing history of scientific rigor as evidenced by our peer-reviewed publications, delivery of drug approvals, strong academic collaborations and talent development.

Our areas of focus include but are not limited to Hematology, Oncology, Immunology, Cardiovascular and Neuroscience. This group integrates scientific learnings from the lab and clinic as well as business insights of multiple functions and leads the development of translational strategies at the franchise level.

Reporting to the Program Management Lead, the incumbent will be part of the late development translational group based in NJ and will be responsible for writing scientific documents including biomarker reports, regulatory documents (eg, non-clinical summaries, translational portions of clinical/pharmacology summaries, briefing books, CSRs, investigator brochures) in conjunction with Translational scientists. This individual will also contribute to abstracts, posters, manuscript and other scientific communications arising from the group.

• In-depth understanding of hematological malignancies or solid tumors or Neuroscience disorders especially the clinical landscape, evolving therapy, competitive scenarios
• Strong understanding of clinical, translational and mechanistic data with BMS assets and novel agents
• Strong background in writing and in communication strategy development, disease and or brand planning, regulatory documents preparation for in-line and late-stage development compounds
• Familiarity and working knowledge of CARA, VERITY or other documentation systems
• Understanding of late-stage drug and translational development processes
• Proven ability to work with global disease teams to develop strategies to support life cycle management efforts tailored to regional markets (i.e, US, EU, CAN)
• Strong verbal and written communication skills with experience in developing written documents such as primary manuscripts/publications/reviews, disease strategies, mechanism slides, regulatory submissions, strategic communications, literature/market/pt segment analyses
• Ability to synthesize complex scientific and business problems into strategy and tactics
• Basic understanding of IP, contracting terms and provisions

• Ensure timely delivery for the TD writing book of work such as pre-clinical reports, and Translational biomarker reports across the disease areas
• In conjunction with TD scientists, establish annual publication goals, publication plan with priority rankings, and estimated timelines for submission, with focus to ensure all deadlines for regulatory submissions/requests are met. Routinely interact with TD Program Manager(s) on status of publications
• Supports regulatory submissions, regulatory interactions,…